Právní předpis byl sestaven k datu 01.03.2017.
Zobrazené znění právního předpisu je účinné od 01.03.2017 do 30.04.2017.
Příloha č. 1 - Seznam č. 1 omamných látek
Příloha č. 2 - Seznam č. 2 omamných látek
Příloha č. 3 - Seznam č. 3 omamných látek
Příloha č. 4 - Seznam č. 4 psychotropních látek
Příloha č. 5 - Seznam č. 5 psychotropních látek
Příloha č. 6 - Seznam č. 6 psychotropních látek
Příloha č. 7 - Seznam č. 7 psychotropních látek
Příloha č. 8 - Seznam č. 8 vybraných přípravků
č. 46/2017 Sb. - Čl. II
463
XXXXXXXX VLÁDY
ze xxx 18. xxxxxxxx 2013
x xxxxxxxxx návykových xxxxx
Xxxxx xxxxxxxx xxxxx §44c xxxx. 1 zákona x. 167/1998 Sb., x návykových látkách x o změně xxxxxxxxx xxxxxxx xxxxxx, xx xxxxx xxxxxx x. 273/2013 Xx.:
§1
Toto nařízení xxxxxxx
x) x příloze č. 1 k xxxxxx nařízení xxxxxx
1. xxxxxxxx látek zařazených xx Xxxxxxx X xxxxx Xxxxxxxx xxxxxx x omamných xxxxxxx1) x
2. xxxxxxx xxxxxxxx xxxxx, s xxxxx xx x xxxxxx xxxxxxx jejich xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx nebo xxxxxxx xxxxxxxx xxxxxx, xxxxxxxx xxxxxxx zacházení xxx xx xxxxxxx xxxxxxxx x xxxxxxxxx, xxxx xx z xxxxxx xxxxxx xxxxx xxxxxxxxxx, xxx xxxxxx xxxxxxxxx xxxxxxxxxx tyto xxxxxx xxxxx xxxx xxxxxxxx x xxxxxxx xxxxx xx xxxxxx nebo xxxxxxx xxxxxxxx modrým xxxxxx xxxxxxxxxx x xxxxxx xxxxxxx rohu xx xxxxxxx horního xxxx,
(xxxx xxx "xxxxxx x. 1 omamných xxxxx"),
x) x příloze č. 2 x xxxxxx nařízení xxxxxx
1. xxxxxxxx látek xxxxxxxxxx xx Xxxxxxx XX podle Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx x
2. xxxxxxx xxxxxxxx xxxxx, u xxxxx xx x xxxxxx xxxxxxx jejich xxxxxxxxxx anebo xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx ohrožují zdraví, xxxxx zabezpečit, xxx xxxxxx přípravky obsahující xxxx omamné xxxxx xxxx vydávány x xxxxxxx xx xxxxxx xxxx xxxxxxx xxx xxxxxxxx modrým xxxxxx,
(xxxx xxx "xxxxxx x. 2 xxxxxxxx látek"),
c) x příloze č. 3 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XX xxxxx Xxxxxxxx úmluvy x xxxxxxxx xxxxxxx x
2. dalších xxxxxxxx xxxxx, u xxxxx xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx zdraví, nutné xxxxxxxxxx, xxx xxxxx x xxxxxxxxx xxxxxxxxxx xxxx xxxxxx xxxxx xxxx používány xxxxx x xxxxxxxx xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxx x xxxxxxxx x xxxxxxxxx,
(xxxx jen "xxxxxx x. 3 xxxxxxxx xxxxx"),
x) x příloze č. 4 x xxxxxx xxxxxxxx xxxxxx
1. psychotropních xxxxx zařazených do Xxxxxxx I podle Xxxxxx o xxxxxxxxxxxxxx xxxxxxx2) a
2. xxxxxxx xxxxxxxxxxxxxx xxxxx, x xxxxx xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx anebo xxxxx, xx bezprostředně xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx zabezpečit, xxx xxxxx x xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxxxxx xxxxx byly xxxxxxxxx xxxxx x omezeným xxxxxxxxx, xxxxxxxx a xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxx x xxxxxxxx x zacházení,
(dále xxx "xxxxxx č. 4 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 5 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XX xxxxx Úmluvy o xxxxxxxxxxxxxx xxxxxxx a
2. xxxxxxx psychotropních xxxxx, x xxxxx je x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx anebo xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx ohrožují xxxxxx, xxxxxxxx xxxxxxx xxxxxxxxx jen xx xxxxxxx xxxxxxxx x xxxxxxxxx, nebo xx x xxxxxx xxxxxx xxxxx xxxxxxxxxx, xxx xxxxxx přípravky xxxxxxxxxx xxxx xxxxxxxxxxxx látky xxxx xxxxxxxx x xxxxxxx pouze na xxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx xxxxxx xxxxxxxxxx x xxxxxx xxxxxxx rohu xx xxxxxxx xxxxxxx xxxx,
(xxxx xxx "xxxxxx x. 5 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 6 x xxxxxx xxxxxxxx seznam xxxxxxxxxxxxxx xxxxx zařazených xx Xxxxxxx XXX xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx,
g) x příloze č. 7 x xxxxxx xxxxxxxx xxxxxx
1. psychotropních xxxxx zařazených xx Xxxxxxx XX xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx x
2. dalších xxxxxxxxxxxxxx xxxxx, x xxxxx je z xxxxxx xxxxxxx xxxxxx xxxxxxxxxx anebo xxxxx, xx xxxxxxxxxxxxx nebo xxxxxxx ohrožují xxxxxx, xxxxx xxxxxxxxxx, aby xxxxxx přípravky xxxxxxxxxx xxxx xxxxx byly xxxxxxxx x xxxxxxx xx xxxxxx nebo xxxxxxx xxx xxxxxxxx xxxxxx pruhem,
(dále xxx "xxxxxx č. 7 xxxxxxxxxxxxxx xxxxx"), a
h) x příloze č. 8 x xxxxxx xxxxxxxx xxxxxx xxxxxxxxx xxxxxxxxxx do Xxxxxxx XXX xxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx,
(xxxx jen "xxxxxx č. 8 xxxxxxxxx xxxxxxxxx").
§2
Xxxx xxxxxxxx bylo xxxxxxxx x souladu xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx 98/34/ES ze dne 22. června 1998 x postupu xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxx x xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx služby xxxxxxxxxx společnosti, x xxxxxxx xxxxx.
§3
Xxxx xxxxxxxx nabývá xxxxxxxxx xxxx 1. xxxxx 2014.
Xxxxxxx x. 1 x nařízení xxxxx x. 463/2013 Sb.
Seznam x. 1 omamných xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx název (XXX) x českém xxxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(5X,6X,7X)-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-4,5-xxxxx- 6,14-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
XxxxxX-xxxx-xxxxxxxxxxxxxx |
(XX)-X-[1-(2-xxxxX-2-xxxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx |
|
|
XxxxxXxxxxxxxx |
(3XX)-6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX,4Xx)-3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxx-xxxxxxxxxxxxxx |
X-{1-[(1XX)-2-xxxxx-1-xxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxxxxx |
X-{1-[(1XX)-1-xxxxxx-2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
XXxxxxxxxx |
(3X,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xX-xxxxxxxxx |
|
|
Xxxxxxxxxx |
X-{1-[2-(4-xxxxx-5-xxx-4,5-xxxxxxx-1X-xxxxxxxx-1-xx)xxxxx]-4-(xxxxxxxxxxxxx) piperidin-4-yl}-N-fenylpropanamid |
|
|
Allylprodin |
3-allyl-4-fenyl-1-methylpiperidin-4-yl-propanoát |
|
|
Anileridin |
elhyl-1-(4-aminofenethyl)-4-fenylpiperidin-4-karboxylát |
|
|
Benzethidin |
ethyl-1-[2-(benzyloxy)ethyl]-4-fenylpiperidin-4-karboxylát |
|
|
Benzylmorfin |
3-(bertzyIoxy)-4.5α-epoxy-17-methylmorfin-7-en-6α-ol |
|
|
Betacethylmethadol |
(3S,6R)-6-{dimethylameno )-4.4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]-3-xxxxxxxxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxX-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
2,2-xxxxxxX-4-[4-(2-xxx-3-xxxxxxxxX-2,3-xxxxxxx-1X-xxxxxxxxxxxx-1-xx) xxxxxxxxxx]xxxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
1-[(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxx]xxxxxxxxxx |
|
|
Xxxxxxxxxx |
X-[2-(X-xxxxxxxx-X-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
3-(xxxxxxxxxxxx)-1,1-xx(2-xxxxxxx)xxx-1-xx |
|
|
Xxxxxxxxx |
1-(3,3-xxxxxxx-3-xxxxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxxx kyselina |
|
|
Difenoxylát |
ethyl-1-(3,3-difenyl-3-kyanpropyl)-4-fenylpiperidin-4-karboxylát |
|
|
Dihydroetorfin |
(5R,6R,7R)-4,5-epoxy-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl- 6,14-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α-xxxx |
|
|
Xxxxxxxxxxx |
[2-(xxxxxxxxxxxxx)xxxxx)]-2-xxxxxx-2,2-xxxxxxx-xxxxxx |
|
|
Xxxxxxxxxxxx |
6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
X,X,1-xxxxxxxxx-3,3-xx(2-xxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxx-xxxxxxx |
xxxxx-2,2-xxxxxxx-4-xxxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
|
Xxxxxxxxx |
(6XX)-4,4-xxxxxxx-6-xxxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(6X)-3,4-xxxxxxxxx-17-xxxxxxxxxxxxxx-6β,14-xxxx |
|
|
Xxxxxxx |
xxxxxxxx (1X,2X,3X,5X)-3-xxxxxxx-8-xxxxxx-9-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxxx, její xxxxxx x xxxxxxxx, x xxxxxxx xx xxxxx xxxxxx xxxxxxx x kokain |
|
|
Ethylmethylthiambuten |
N-ethyl-N,1-dimethyl-3,3-bis(2-thienyl)-2-propenylamin |
|
|
Etonitazen |
1-[2-(deethylamino)ethyl]-2-(4-ethoxybenzyl]-5-nitro-1H-benzimidazol |
|
|
Etoxeridin |
ethyl-4-fenyl-1-[2-(2-hydroxyethoxy)ethyl]piperidin-4-karboxylát |
|
|
Fenadaxon |
4,4-difenyl-6-morfolinoheptan-3-on |
|
|
Fenampromid |
N-(1-methyl-2-piperidinoethyl)propananilid |
|
|
Fenazocin |
(2RS,6R,11R)-3-fenethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano- 3-xxxxxxxxxx-8-xx |
|
|
Xxxxxxxxxx |
17-xxxxxxxXxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxX-4-xxxxX-1-[2-(xxxxxxxxxxx)xxxxx]xxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxXxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α,14-xxxxx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxxxx |
xxxxx-4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxx-5-xxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
xxxxxx-1-xxxxxxxx-4-(X-xxxxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
2-(4-xxxxxxxxxxx)-1-[2-(xxxxxxxxxxxxx)xxxxx]-5-xxxxx-1X-xxxxxxxxxxxx |
|
|
Xxxxxxx |
xxxxxxxx 2-{[X-(4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xxxxxx) xxxxx]xxx}xxxxxx |
|
|
Xxxx - xxxx |
Xxxxxx xxxx |
|
|
Xxxxxx |
(1X,2X,3X,5X)-3-(xxxxxxxxxx)-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2- karboxylát |
|
|
Koncentrát x xxxxxxxx |
Xxxxxxxxxxx x xxxxxx alkaloidů získaný xxxxxxxxxxxxxx xxxxxxx xxxxxxxx |
|
|
Xxxxxx xxxxxxx a tinktura |
Extrakt x xxxxxxxx x xxxxxx |
|
|
Xxxxxx xxx xxxxxxx xxxxxxx |
xxxxxx určené x xxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxxxxxxxxxxx xxxxxxx xxxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
1-xxxxx-2-[(9X,13X,14X)3-xxxxxxxxxxxxxxx-17-xx]xxxxx-1-xx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-3-xxxxxxxx-17-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxx xxxxxxxxxxxxxxx [(+)-3-methoxy-17- xxxxxxxxxxxxxx] je xxxxx xx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x xxxx xxxxxxx |
|
Xxxxxxxxxxx |
(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
Xxxxxxxxxx |
(9X,13X,14X)-17-xxxxxxxxxxxxxx-3-xx |
Xxxxxxxxxxxxxx xxxxxxxxxxx [(+)-3-xxxxxxx-17- methylmorfinan] xx xxxxx xx seznamu xxxxxxxx xxxxx uvedených x xxxx xxxxxxx |
|
Xxxxxxxxx |
(2X,6X,11X)-3,6,11-xxxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxxxx-3- xxxxxxxxx-8-xx |
|
|
Xxxxxxxx |
(6XX)-6-(xxxxxxxxxxxxx)4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxx, xxxxxxxxxxx |
4-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
4,5α-xxxxx-6,17-xxxxxxxxxxxxxx-6-xx-3-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
4,5-xxxxx-6,17-xxxxxxxxxxxxxxxx-3,6-xxxx |
|
|
Xxxxxxx |
4,5-xxxxx-3-xxxxxxx-5,17-xxxxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxx, meziprodukt |
2,2-difenyl-3-methyl-4-rnorfolinobutanová xxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
X-(1-xxxxxxxx-3-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx |
3-Xxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxx |
X-{(3XX)-3-xxxxxx-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
3-xxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxx |
4,5α-xxxxx-17-xxxxxXxxxxxx-7-xx-3,6α-xxxx |
|
|
Xxxxxx xxxxxxxxxxx |
4,5α-xxxxx-3,6α-xxxxxxxxx-17,17-xxxxxxxxxxxxxx-7-xx-17-xxx-xxxxxx |
x jiné xxxxxxxx xxxxxxx se xxxxxxxxxx xxxxxxx včetně xxxxxxxx morfin-N-oxidu (i xxxxxx-X-xxxxx) |
|
Xxxxxx-X-xxxx |
4,5α -epoxy-17-methylmorfin-7-en-3,6α-diol-17-oxid |
|
|
DesmethyIprodin |
4-fenyl-1-methylpiperidin-4-yl-propanoát |
MPPP |
|
Myrofin |
3-(benzyloxy)-4,5α-epoxy-17-methylmorfin-7-en-6-yl-tetradekanoát |
|
|
Nikomorfin |
4,5α-epoxy-17-methylmorfin-7-en-3,6α-diyl-dinikotinát |
|
|
Noracymethadol |
4,4-difenyl-6-(methylamono)heptan-3-yl-acetát |
|
|
Norlevorfanol |
(9R,13R,14R)-morfinan-3-ol |
|
|
Normethadon |
6-(dimethylamono)-4,4-difenylhexan-3-on |
|
|
Normorfin |
4,5α-epoxymorfin-7-en-3,6α-dioI |
|
|
Norpipanon |
4,4-defenyl-6-piperidinohexan-3-on |
|
|
Opium |
Kromě xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx, jejichž xxxxxx xxxxxx xx xxxxx než X4 xxxx XX2 |
|
|
Xxxxxxxx |
4,5α-xxxxx-6-xxxxxxx-17-xxxxxxxxxxxxx-6,8(14)-xxxx-3-xx |
|
|
Xxxxxxxx |
(5X)-4,5-xxxxx-14-xxxxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxx |
(5X)-4,5-xxxxx-3,14-xxxxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxxxxxx |
X-(1-xxxxxxxXxxxxxxxxx-4-xx)-4'-xxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-1-xxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
XXXXX |
|
Xxxxxxxx |
xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx X |
4-xxxxx-1-xxxxxxxxxxxxxxx-1-xxxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx X |
xxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx X |
xxxxxxxx 4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxxx |
|
|
Xxxxxxxxx |
xxxxx-1-(3-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
1'-(3,3-xxxxxxx-3-xxxxxxxxxx-4'-xxxxxx-1,4'-xxxxxxxxxxx |
|
|
Xxxxxxxxxxx |
4-xxxxx-1,3-xxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxxxxxX-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
(9XX,13XX,14XX)-3-xxxxxxx-17-xxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
Xxxxxxxxxx |
(9XX,13XX,14XX)-17-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxx |
xxxxxx-3-[4-(X-xxxxxxxxxxxxxxx)4-(xxxxxxxxxxxxxxx)]xxxxxxxxxx]xxxxxxxxx |
|
|
Xxxxxxxxxx |
X-{4-(xxxxxxxxxxxxx)-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
3-[(1X,2X)-3-(xxxxxxxxxxxxx)-1-xxxxx-2-xxxxxxxxxxxx]xxxxx |
|
|
Xxxxxxx |
4,5α-xxxxx-3,6-xxxxxxxxx-17-xxxxxxxxxxxxxxx-6,8-xxxx |
|
|
Xxxxxxxx |
(5X)-4,5-xxxxx-3-xxxxxxx-17-xxxxxXxxxxxx-6-xx-6-xx-xxxxxx |
|
|
Xxxxxxxxxxxx |
X-{1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxx |
xxxxx-(1XX,2XX)-2-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxxx-3-xx-1-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(XX)-4-xxxxx-4-(1,2,5-xxxxxxxxxxxxxxxxxx-4-xx)xxxxxxxxx |
Xxxxxx xxxxxxx xxxxxxxx látek xxxxxxxxx x xxxxx xxxxxxx, dále xxxxxx x ethery omamných xxxxx xxxxxxxxx x xxxxx seznamu x xxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx včetně xxxx xxxxxxx, xxxxxx x xxxxx xx xxxxx xxxxxxxxx, xxx xxxx xxxx xxxxx xxxxxxxxx.
Xxxxxxx x. 2 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 2 omamných xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx název (XXX) x xxxxxx xxxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxx |
(1X,2X)-1-xxxxxx-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxx-xxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
4,5α-xxxxx-17-xxxxxx-3-(2-xxxxxxxxxxxxxxx)xxxxxx-7-xx-6α-xx |
|
|
Xxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx--7-xx-6-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
X-[(1XX)-1-xxxxxx-2-xxxxxxxxxxxxxxx]-X-(2-xxxxxxx)xxxxxxxxxx |
Xxxxxx xxxxxxx omamných xxxxx xxxxxxxxx x xxxxx seznamu, dále xxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx, včetně xxxx xxxxxxx xxxxx xxxxxxxxx x tomto xxxxxxx xx xxxxx případech, xxx xxxx xxxx xxxxx xxxxxxxxx.
Xxxxxxx x. 3 x nařízení xxxxx x. 463/2013 Sb.
Seznam x. 3 omamných xxxxx
|
Xxxxxxxxxxx nechráněný název (XXX) v xxxxxx xxxxxx |
Xxxxxxxx název xxxxx XXXXX |
Xxxxxxxx |
| Xxxxxxxxxxxxxx | X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxx | |
| Xxxxxxxxxxxxxxxx | X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxx-2-xxxxxx | |
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxx |
[5X,6X,7X,14X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx- 17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxx |
(5X,6X)-4,5-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6-xxxx-xxxxxxxx |
|
|
Xxxxxxxxxxx |
1-[4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxx-4-xx]xxxxxx-1-xx |
|
|
Xxxxxx |
X výjimkou xxxxxx xxx léčebné xxxxxxx xxxxxxx x xxxxxxx x. 1 |
|
|
Pryskyřice x xxxxxx |
Xxxxxx xxxx xxxxxxxx látek xxxxxxxxx x xxxx skupině xx xxxxx xxxxxxxxx, xxx xxxx xxxx xxxxx xxxxxxxxx.
Xxxxxxx x. 4 x xxxxxxxx xxxxx x. 463/2013 Sb.
Seznam x. 4 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx / xxxxxx xxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx nebo další xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
XX-XXXXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XX-XXXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXXXX |
X-[1-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxx]-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-[(4-xxxxxxxxxx)xxxxxx] xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XX-7921 |
3,4-xxxxxxx-X-{[1-(xxxxxxxxxxxxx)xxxxxxxxxx]xxxxxx}xxxxxxxx |
||
|
XX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-XXXXXX |
xxxxxx (2X)-2-{[1-(xxxxxxxxxxxxxxxx)xxxxx-3-xxxxxxxx]xxxxx}-3-xxxxxxxxxxxxxx |
||
|
5-Xxxxxxxxxxxxxxxx |
5-XXX |
5-(2-xxxxxxxxxxx)xxxxx |
|
|
XXXXXXX |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3 -karboxamid |
AKB48 |
|
|
bk-PMA |
2-amino-1-(4-methoxyfenyl) propan-1-on |
||
|
Methedron |
bk-PMMA |
1-(4-methoxyfenyl)-2-(methylamino)propan-1-on |
|
|
2-Brommethkathinon |
2-BMC |
(RS)-1-(2-bromfenyl)-2-methylaminopropan-1-on |
|
|
3-Brommethkathinon |
3-BMC |
(RS)-1-(3 -xxxxxxxxx)-2-xxxxxxxxxxxxxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxx)-2-xxxxxxxxxxxxxxxxx-1-xx |
Xxxxxxxxx |
|
25X-XXXXx |
2-(4-xxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
Xxxxx-36 |
|
|
25X-XXXXx |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
2X-X-XXXXx |
|
|
25X-XXXXx |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
XXXXx-2X-X |
|
|
Xxxxx-Xxxxxxxxx |
(2X)-1-(4-xxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxx-2-xxxx |
||
|
Xxxxxxx |
xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx)]xxxxx-1-xx |
X1 |
|
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
XXX |
|
2X-X |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xxxx |
||
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
x-XXX |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxxx |
2X-X |
(4-xxx-2,5-xxxxxxxxxxxxxxxxx)xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-7 |
[4-(xxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
XX-47,497 |
2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-5-(2-xxxxxxxxxxx-2-xx)xxxxx |
||
|
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
XX-13 |
|
|
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-2-xxxxx-xxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx-2-xxxxx xxxxxxxx |
X-(2-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
|
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
x-Xxxxxx-4-xxxxxxxxxxxxxx |
4,4'-XXXX |
4-xxxxxx-5-(4-xxxxxxxxxxx)-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
x4-XXXX |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x] xxxxxxx-1-xx |
|
|
3,4-Xxxxxxxxxxxxxxxxxxx |
3,4-XXXX |
1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxx |
XXX |
X-[2-(xxxxx-3-xx)xxxxx]-X,X-xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2,5-Xxxxxxxxx-4-xxxxxxxxxxxxxx |
XXX |
1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX, XXX |
(2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2,5-Xxxxxxxxx-4-xxxxxxxxxxxx |
XXX |
1-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxx |
Xxxxxxx |
(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxx |
(XX)-xxxxx 2-xxxxx-2-xxxxxxxxx-2-xxxxxxxx |
||
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-2-xxxxxxxxxxx-1-(2-xxxxxxxxxx)xxxxxxx-1-xx |
|
|
3 -Ethylmethkathinon |
3-EMC |
(RS)-2-methylamino-1-(3-ethylfenyl)propane-1-on |
|
|
4-Ethylmethkathinon |
4-EMC |
(RS)-2-methylamino-1-(4-ethylfenyl)propane-1-on |
|
|
Etryptamin |
3-(2-aminobutyl)indol |
||
|
2-Fluoramfetamin |
2-FA |
1-(2-fluorfenyl)propan-2-amin |
|
|
3-Fluoramfetamin |
3-FA |
1-(3-fluorfenyl)propan-2-amin |
|
|
4-Fluoramfetamin |
4-FA |
1-(4-fluorfenyl)propan-2-amin |
|
|
5F-ADBICA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid |
||
|
5F-APINACA |
5F-AKB48 |
N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-indazol-3-karboxamid |
|
|
5F-AMB-PINACA |
5F-AMB |
Methyl 2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx |
5X-XXX |
|
Xxxxxxxx butanamid xxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]-xxxxxxxxx |
||
|
4-Xxxxx-xxxxxxxxxxxxx |
4X-XX |
X-(4-xxxxxxxxxxx)-X-[(1-(2-xxxxxxxxxx)-4 xxxxxxxxxxx)]xxxxxxxxx |
|
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
5X-XXXX-XXXXXX |
xxxxxx (S)-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát |
||
|
5FUR-144 |
[1-(5-fluorpentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyklopropyl)methanon |
XLR-11 |
|
|
Furanylfentanyl |
FU-F |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-furan-2-karboxamid |
2-furanoylfentanyl |
|
Hydroxytenamfetamin |
(2RS)-N-hydroxy-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
||
|
(iso)Butyryl-F-fentanyl X-xxxxxx xxxxxx |
X-(1-xxxxxxxxxxxxxxx-4-xx)-X-(4-xxxxxxxxxx)-xxxxxxxxx |
||
|
XXX-018 |
(xxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3 -yl)methanon |
||
|
JWH-073 |
(1-butyl-1H-indol-3-yl)(naftalen-1-yl)methanon |
||
|
JWH-081 |
(4-methoxynaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon |
||
|
JWH-122 |
(4-methylnaftalen-1-yl)(1-pentyl- 1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-200 |
[1-(2-xxxxxxxxxxxxxx)-1X-xxxxx-3-xx] (xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-250 |
2-(2-xxxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxx-1-xx |
||
|
XXX-398 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
Xxxxxxxx |
(2XX)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
||
|
(+)-Xxxxxxxx |
XXX, XXX-25 |
(+)-8β-(3,3-xxxxxxxxxxxxxx)-6-xxxxxx-9,10-xxxxxxxxxxxxxxxx |
|
|
2-Xxxxxxxxxxxxxxx |
2-XX |
(2XX)-1-(2-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxx |
3-XX |
(2XX)-1-(3 -xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxx |
4-XX |
(2XX)-1-(4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
XXXX |
1-xxxxxx-4-xxxxxxxxxxxxxxx |
||
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(3-xxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
XXX |
(2XX)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxxxxxx |
XXX, XXXX |
(2XX)-X-xxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxx |
xx-XXXX |
2-xxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-X-xxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
XXXX-XXXXXX |
X-[[1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx]-3-xxxxxx- valine, xxxxxx xxxxx |
||
|
XXXX-XXXXXXXX |
2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx] amino]-3,3- xxxxxxxx-xxxxxxxx |
||
|
3,4-Xxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
1-[3,4-(xxxxxxxxxxxxx)xxxxx]-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
XXXX |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
5-XxX-XXX |
5-xxxxxxx-α-xxxxxxxxxxxxxxx |
||
|
4-Xxxxxxxxxxxx xxxxxxxx |
4-XxX-XX |
X-(4-xxxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx] xxxxxxxxx |
|
|
5-XxX-XXXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-(xxxx-2-xx-1-xx)xxxx-2-xx-1-xxxx |
||
|
3-Xxxxxxxxxxxxxxxxxx |
3-XxX-XXX |
1-[1-(3-xxxxxxx xxxxx)xxxxxxxxxx]xxxxxxxxx |
|
|
Xxxxxxxx |
3,4,5-xxxxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
(±)-5-xxxxx-4-xxxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
2-(xxxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-[5-xxxxxxx-3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX |
X-xxxxxx-1-(xxxxxxx-2-xx)xxxxxx-2-xxxx |
|
|
XX-45 |
1-xxxxxxxxxx-4-(1,2-xxxxxxxxxxxx)-xxxxxxxxx |
||
|
2-Xxxxxxxxxxxxxxxxxxx |
2-XXX |
(2XX)-1-[2-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxxx |
3-XXX |
(2XX)-1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxxx |
4-XXX |
(2XX)-1-[4-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxx |
Xxxxxxx |
1-(xxxxxxxx-2-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
X-2482 |
|
XX xxxxxxxx |
X-3217 |
X-(2-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
X-Xxxxxxxxxxxxxxxxx |
XXX |
3-{-2-[(xxxxxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxxxxxxxx} fenol |
|
|
Parahexyl |
3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol |
||
|
Eticyklidin |
PCE |
N-ethyl-1-fenylcyklohexylamin |
|
|
Pentedron |
pentedron |
1-fenyl-2-(methylamino)pentan-1-on |
|
|
p-Fluorfenylpiperazin |
pFPP |
1-(4-fluorfenyl)piperazin |
|
|
Methoxyamfetamin |
PMA |
(2RS)-1-(4-methoxyfenyl)propan-2-amin |
|
|
Methoxymetamfetamin |
PMMA |
1-(4-methoxyfenyl)-N-methylpropan-2-amin |
|
|
Psilocybin |
3-[2-(dimethylamino)ethyl]-1H-indol-4-yl-dihydrogen-fosfát |
||
|
Psilocin |
Psilotsin |
3-[2-(dimethylamino)ethyl]-1H-indol-4-ol |
|
|
α-PVT |
2-(pyrrolidin-1-yl)-1-(thiofen-2-yl)pentan-1-on |
||
|
Rolicyklidin |
PHP, PCPY |
1-(1-fenylcyklohexyl)pyrrolidin |
|
|
α -PVP |
1-fenyl-2-(pyrrolidin-1-yl)-1-pentan-1-on |
||
|
Salvinorin X |
Xxxxxxxxxx A |
methyl-(2RS,4aR,6aR,7R,9RS,10aRS,10bR)-9-acetoxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxododekahydro-1H-benzo[f]isochromen-7-karboxylát |
|
|
Tenocyklidin |
TCP |
1-[1-(2-thienyl)cyklohexyl]piperidin |
|
|
1-(3-Trifluormethylfenyl)piperazin |
TFMPP |
1-[3-(trifluormethyl)fenyl]piperazin |
|
|
Tetrahydrokanabinol |
THC |
D6a(10a)-, X6x(7)-, X7-, D8-, D10-, X9(11)-xxxxxxxxxxxxxxxxxxxx x xxxxxx xxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(3,4,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx-2 |
XXX-2 |
(2XX)-1-(2,4,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXXX-018 |
|
|
X-47700 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
|
X-15 |
4-xxxxx-X-(1-xxxxxxxxxxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
||
|
X-18 |
4-xxxxx-X-(1-[2-(4-xxxxxxxxxx)xxxxx]-xxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
Xxxxxx xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxx, až xx xxxxxxxx výjimky, xxxxxxxxx x xxxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx tyto xxxxxxxxxxxxx xxxxx existovat xxxxx xxxxxxxxxx chemického xxxxxxxx x solí xxxxxxxxxxxxxx xxxxx xxxxxxxxx v xxxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxxx existovat.
Příloha x. 5 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 5 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x českém xxxxxx |
Xxxxx xxxxxxxxxxx nechráněný xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 7-[(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl) xxxxx]xxxxxxxxx |
||
|
Xxxxxxxxxx |
(2X)-2-[(5X,6X,7X,14X)-17-(xxxxxxxxxxxxxxxxx)-4,5α-xxxxx-3- xxxxxxx-6-xxxxxxx-6α,14-xxxxxxxxxxxxxx-7x-xx]-3,3-xxxxxxxx xxxxx-2-xx |
||
|
Xxxxxxxxxxxxxxxxxxxxx amin |
2C-B |
(4-brom-2,5-dimethoxyfenethyl)amin |
|
|
Dexamfetamin |
(2S)-1-fenylpropan-2-amin |
||
|
Fencyklidin |
PCP |
1-(1-fenylcyklohexyl)piperidin |
|
|
Fenetylin |
7-(2-{[(2RS)-1-fenylpropan-2-yl]amino}ethyl)-1,3-dimethyl-7H- xxxxx-2,6-xxxx |
||
|
Xxxxxxxxxxx |
2-xxxxX-3-xxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1X-1,4-xxxxxxxxxxxxx-2(3X)-xx |
||
|
XXX |
xxxxxxxx 4-hydroxybutanová |
||
|
Levamfetamin |
(2RS)-1-fenylpropan-2-amin |
||
|
Levmetamfetamin |
(2RS)-1-fenyl-N-methylpropan-2-amin |
||
|
Meklochalon |
3-(2-chlorfenyl)-2-methyl-1,2-dihydrochinazolin-4(3H)-on |
||
|
Metachalon |
2-rnethyl-3-(2-methylfenyl)-1,2-dihydrochinazolin-4(3H)-on |
||
|
Metamfetamin |
(2S)-1-fenyl-N-methylpropan-2-amin |
||
|
Metamfetamin racemický |
(2RS)-1-fenyl-N-methylpropan-2-amin |
||
|
Methylfenidát |
methyl-(2RS)-2-fenyl-2-[(2RS)-piperidin-2-yl]acetát |
||
|
Sekobarbital |
kyselina 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxx-9-XXX |
Δ9-xxxxxxxxxxxxxxxxxxx (XXX) x xxxx stereoizomery |
např. (-)-xxxxx-Δ9-XXX |
|
Xxxxxxxx |
(2XX)-1-xxxxx-1-xxxxxxx-3-[4-(2-xxxxxxxxxxxxxxx)xxxxxxxxx-1-xx] xxxxxx-2xx |
Xxxxxx solí látek xxxxxxxxx v xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx existence xxxxxxxx xxxx xx xxxxx.
Xxxxxxx č. 6 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 6 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx název (XXX) x českém xxxxxx |
Xxxxx xxxxxxxxxxx nechráněný xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
xxxxxxxx 5-(1-xxxxxxxx-1-xx-1-xx)-5-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(3XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx |
||
|
Xxxxxx |
(+)-xxxxxxxxxxxxxxxx |
(1X,2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxxxx |
(2X,6X,11X)-6,11-xxxxxxxx-3-(3-xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- xxxxxxxxx-2,6-xxxxxxx-3-xxxxxxxxxx-8-xx |
||
|
Xxxxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5[(1XX)-1-xxxxxxxxxxx]xxxxxxxxxxx |
Xxxxxx xxxx látek uvedených x této xxxxxxx xx xxxxx případech, xxx xxxxxxxxx xxxxxxxx xxxx xx xxxxx.
Příloha x. 7 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 7 psychotropních xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxx |
8-xxxxx-6-xxxxx-1-xxxxxx-4X.[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
2-(xxxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
||
|
Xxxxxxxx |
5-xxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
(+)-X-xxxxxx-X-(2-xxxxx-1-xxxxxxxxxxx)-X-xxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
1-xxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
7-xxxx-5.(2-xxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
2-xxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxxx[4,3-x]xxxxxxxx |
||
|
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2xx |
||
|
Xxxxxxxxx |
8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
Xxxxxxxxxxxxx |
1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx |
||
|
Xxxxxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3- xxxxxxxxxx |
||
| Xxxxxxxxx | 7-xxxxx-5-(2-xxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
|
Xxxxxxxxxxxxx |
(2X,3X)-2-xxxxx-3,4-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-3-xxxxxxxxxxxx[2.2.1]xxxxxx |
||
|
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx kyselina |
||
|
Fenproprex |
(±)-1-fenyl-2-[(2-kyanethyl)amino]propan |
||
|
Fentemin |
2-fenyl-1,1-dimethylethylamin |
||
|
FIudiazepam |
7-chlor-5-(2-fluorfenyl)-1-methyl-1,3-dihydro-2G-1,4-benzodiazepin-2-on |
||
|
FIurrazepam |
7-chlor-2-[2-(diethylamino)ethyl]-5-(2-fluorfenyl)-1,3-dihydro-2H-1,4-bezodiazepin- 2-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-(2,2,2-xxxxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxx |
10-xxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx -6(5H)-on |
||
|
Chlordiazeproxid |
7-chlor-5-fenyl-2-(methylamono)-3H-1,4-benzodiazepin-4-oxid |
||
|
Kamazepam |
7-chIor-5-fenyl-1-methyl-2-oxo-1,3-dihydro-2H-1,4-benzodiazepin-3-yl-dimethyl xxxxxxxx |
||
|
Xxxxxxx |
(2XX)-2-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
11-xxxxx-12x-xxxxx-2,8-xxxxxxxx-8,12x-xxxxxxx-4X-[1,3]xxxxxxx[3,2-x][1,4] xxxxxxxxxxxx-4,7(6X)-xxxx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1X-1,5-xxxxxxxxxxxx-2,4(3X,5X]-xxxx |
||
|
Xxxxxxxxxx |
5-{2-xxxxxxxxxX}-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-2-xxx--2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-xxxxxx[2,3-x][1,4]xxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
10-xxxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4] xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxxxx |
XXX |
(-)-1-(xxxxxxxxxxxxx)-1,2-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)-2-[(4-xxxxxxxxxxxxxxx-1-xx)xxxxxx]-8-xxxxx-2,4-xxxxxxx-1X- xxxxxxxx[1,2-x][1,4]xxxxxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2 -xx |
||
|
Xxxxxxxx |
5-(4-xxxxxxxxxx)-2,5-xxxxxxx-3X-xxxxxxx[2,1-α]-xxxxxxxx-5-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
(±)-2-[(3-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
2-xxxxxx-2-xxxxxxxxxxxx-1,3-xxxx-xxxxxxxxxx |
||
|
Xxxxxxxx |
X-(xxxxxxxxxxxxxx)-3-(2-xxxxx-1-xxxxxxxxxxx)xxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxx |
5-xxxxx-5-xxxxx-1-xxxxxxxxxxxxxxxxx kyselina |
||
|
Methyprylon |
3,3-diethyl-5-methylpiperidin-2,4-dion |
||
|
Midazolam |
8-chlor-6-(2-fluorfenyl)-1-methyl-4H-imidazol[1,5-α][1,4]bezodiazepin |
||
|
Nimetazepam |
5-fenyI-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Nitrazepam |
5-fenyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Nordazepam |
7-chlor-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Oxazepalll |
7-chlor-5-fenyl-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Oxazalant |
10-chlor-11b-fenyl-2-methyl-2,3,7,11b-tetrahydroozazolo[3,2-d][1,4] xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxx |
5-xxxxX-2-xxxxx-1,3 -xxxxxxxxxx-4-xx |
||
|
Xxxxxxxxx |
7-xxxxxx-4-xxxxx-1-(xxxx-2-xx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxx |
xxxxxxX(2-xxxxxxxxx)xxxxxxxx |
||
|
Xxxxxxxx |
7-xxxxx-1-(xxxxxxxxxxxxxxxxx)-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxx |
(±)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxx |
5-xxxxx-5-(1-xxxxxxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxx |
(XX)-7-xxxxx-5-xxxxx-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-(xxxxxxxx-1-xx-1-xx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-α][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
5-(1-xxxxxxxxxxx)-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxx |
X,X,6-xxxxxxxxx-2-(4-xxxxxxxxxxx)xxxxxxxx[1,2-α]xxxxxxx-3-xxxxxxxx |
Xxxxxx xxxx látek xxxxxxxxx v xxxx xxxxxxx ve xxxxx xxxxxxxxx, xxx xxxxxxxxx xxxxxxxx xxxx je xxxxx.
Xxxxxxx č. 8 x nařízení vlády x. 463/2013 Xx.
Xxxxxx x. 8 xxxxxxxxx xxxxxxxxx
|
Xxxxxxxxx obsahující: |
Podmínky: |
||
|
1) |
jednu x xxxxxxxx xxxxx: xxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxx xxxxXxxxxxx xxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx |
Xxxxx xxxxxxxxx xxxxx xxxx více xxxxxxx látek (xxxxxxx xxxx xxxxxxxx) x xxxxxxxx omamné xxxxx |
|
|
x) |
x xxxxx tabletě, xxxxxxx, xxxxxx, xxxxx, příp. x jiné lékové xxxxx xxxxx xxxxxxxxxx 100 mg, |
||
|
b) |
v xxxxxxx xxxxx být xxxxxxxxxxx xxxxx xxx 2,5 % |
||
|
2) |
xxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxx xxxxx xxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx xxxxx 0,5 mg. |
|
b) |
Množství xxxxxxx-xxxxxxx xxxx xxx xxxxxxx 5 % x xxxxxxxx xxxxxxxxxxxx x xxxxx xxxxxxx, xxxxxx, xxxxxx, čípku, xxxx. xxxx xxxxxx formě. |
||
|
3) |
difenoxylát |
a) |
Množství xxxxxxxxxxxx nesmí přesáhnout x xxxxx xxxxxxx, xxxxxxx, ampuli, čípku, xxxx. x jiné xxxxxx xxxxx 2,5 xx. |
|
x) |
Xxxxxxxx xxxxxxx-xxxxxxx xxxx xxx nejméně 1 % x xxxxxxxx xxxxxxxxxxxx v xxxxx xxxxxxx, tobolce, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx xxxxx. |
||
|
4) |
xxxxxxxxxxxxxxxx |
Xxxxxxxx xxxxxxxxxxxxxxxxx |
|
|
x) |
xxxxx přesáhnout 135 xx v jedné xxxxxxx, tobolce, xxxxxx, xxxxx, xxxx. x xxxx lékové xxxxx. |
||
|
x) |
x xxxxxxx xxxxx být xxxxxxxxxxx xxxxx než 2,5 %. |
||
|
Xxxxxxxxx xxxxx xxxxxxxxx xxxxxx xxxxxxxxxxxx xxxxx. |
|||
|
5) |
xxxxxx |
Xxxxxxxx kokainu xxxxx xxxxxxxxxx 0,1 % xxxxxxx. |
|
|
6) |
xxxxx nebo morfin |
a) |
Množství xxxxxxx xxxxx přesáhnout 0,2 %. |
|
x) |
Xxxx xxxxx xxxxxxxxx xxxxx xxxx xxxx dalších xxxxx (xxxxxxx však xxxxxxxx). |
||
|
Xxxxxx xxxxx x xxxxxxxxx xxxxxxxx xxxxx xxx xxxxxx xxxxxxx xxxx x xxxxxxx množství, xxx xxxxxxxx veřejné xxxxxx |
|||
|
7) |
xxxxxxxxxxxxx prášek s xxxxx |
x) |
Xxxxxxxx xxxx x xxxxxx nesmí xxx xxxxx xxx 10 %. |
|
x) |
Xxxxxxxx xxxxxxxxxxxxxxx xxxxxx xxxxx xxx xxxxx xxx 10 %. |
||
|
c} |
Množství xxxxx xxxx xxxx xxxxxxx xxxxx (nikoliv xxxx ornamných) xxxxx xxx nižší než 80%. |
||
|
8) |
xxxxxxxxx |
x) |
Xxxxxxxxx xxxxxxxxx xxxxx xxxxxxxxxx 100 xx x jedné xxxxxxx, xxxxxxx, xxxxxx, čípku, xxxx. x xxxx Xxxxxx xxxxx. |
|
x) |
Xxxxxxxxx xxxxxxxxxxxxxx x xxxxxxxxx musí xxx xxxxxxx xxxxxx xxxx xxxxx xxx xxxxxxxxx. |
||
Xxxxxx homeopaticky vyrobených xxxxxxxxx, xxxxxxx xxxxxx xxxxxx xx xxxxx xxx D4 nebo XX2.
Xx. XX
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (EU) 2015/1535 xx dne 9. xxxx 2015 o xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx společnosti.
Čl. XX xxxxxx xxxxxxx xxxxxxxxx x. 46/2017 Sb. x xxxxxxxxx xx 1.3.2017
Xxxxxx xxxxxxx č. 463/2013 Xx. xxxxx xxxxxxxxx xxxx 1.1.2014.
Ve xxxxx xxxxxx xxxxxxxx xxxxxxxx xxxx xxxxxxxxxx xxxxx x doplnění xxxxxxxxxxx xxxxxxx xxxxxxxxx x.:
243/2015 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx
x xxxxxxxxx xx 1.10.2015
46/2017 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Sb., o xxxxxxxxx xxxxxxxxxx xxxxx, xx znění xxxxxxxx xxxxx č. 243/2015 Xx.
x xxxxxxxxx od 1.3.2017 x xxxxxxxx xxxxxxxxx xxxxxxxxxx, která xxxxxxxx účinnosti 1.5.2017
30/2018 Xx., xxxxxx xx xxxx xxxxxxxx vlády x. 463/2013 Sb., x xxxxxxxxx návykových xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 8.3.2018
242/2018 Sb., xxxxxx se mění xxxxxxxx vlády x. 463/2013 Xx., x xxxxxxxxx návykových látek, xx xxxxx pozdějších xxxxxxxx
x účinností xx 25.10.2018
184/2021 Sb., xxxxxx xx mění xxxxxxxx xxxxx x. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx látek, xx xxxxx pozdějších předpisů
s xxxxxxxxx xx 3.6.2021
159/2022 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, ve xxxxx xxxxxxxxxx předpisů
s účinností xx 1.7.2022
228/2023 Sb., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., o xxxxxxxxx návykových látek, xx znění xxxxxxxxxx xxxxxxxx
x účinností od 1.8.2023
52/2024 Sb., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx od 6.3.2024 x 1.1.2025
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx jich xxxxxx derogační změna xxxxx uvedeného xxxxxxxx xxxxxxxx.
1) Jednotná úmluva x omamných xxxxxxx, xxxxxxxxx xxx č. 47/1965 Sb., xx xxxxx Xxxxxxxxx x změnách Jednotné xxxxxx o omamných xxxxxxx, xxxxxxxxxxx xxx č. 458/1991 Sb.
2) Xxxxxx o xxxxxxxxxxxxxx xxxxxxx, vyhlášená xxx č. 62/1989 Sb.